GlobeNewswire 04/09/2019 Oxford Biomedica Interim Results
GlobeNewswire 12/08/2019 Global Gene Therapy Market, 2019-2026: Size, Share & Trends Analysis & Forecast by Vector, Indicatio...
GlobeNewswire 09/08/2019 Axovant Announces Corporate Updates and Financial Results for First Fiscal Quarter Ended June 30, 20...
GlobeNewswire 24/07/2019 The Alliance for Regenerative Medicine Releases List of Presenting Companies at the 2019 Cell & Gene...
GlobeNewswire 11/06/2019 Axovant Announces Financial Results and Corporate Updates for Fourth Quarter and Fiscal Year Ended M...
GlobeNewswire 26/03/2019 Oxford Biomedica notes the Japanese approval of Kymriah® (tisagenlecleucel), the first CAR-T cell th...
GlobeNewswire 14/03/2019 Oxford Biomedica plc: Preliminary results for the year ended 31 December 2018
GlobeNewswire 13/02/2019 The Alliance for Regenerative Medicine Releases Agenda for 2019 Cell & Gene Meeting on the Mediterra...
GlobeNewswire 07/02/2019 Axovant Announces Third Fiscal Quarter 2018 Financial Results and Corporate Updates
GlobeNewswire 07/02/2019 The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sevent...
GlobeNewswire 17/01/2019 The Alliance for Regenerative Medicine Releases Initial Slate of Presenting Companies at the 2019 In...
GlobeNewswire 03/01/2019 Axovant Announces Presentation at J.P. Morgan Healthcare Conference and Anticipated 2019 Clinical De...
GlobeNewswire 02/01/2019 Global $800+ Mn Viral Vector Manufacturing Market to 2023
GlobeNewswire 08/11/2018 Global Gene Therapy Market to 2020 with a Focus on the U.S.
GlobeNewswire 07/11/2018 Axovant Announces Second Fiscal Quarter 2018 Financial Results and Corporate Updates
GlobeNewswire 27/09/2018 Global Genetic Modification Therapies Clinical Applications Market to 2023
GlobeNewswire 13/09/2018 Oxford BioMedica announces further capacity expansion with new facility
GlobeNewswire 13/09/2018 OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2018
GlobeNewswire 07/09/2018 CAR-T Cell Therapy Market, 2024
GlobeNewswire 28/08/2018 Kymriah® (tisagenlecleucel, formerly CTL019) receives European Commission Approval
GlobeNewswire 13/08/2018 Gene Therapy Market, 2018-2030 - Around 300 Product Candidates Under Various Stages of Development f...
GlobeNewswire 07/08/2018 Axovant Announces First Fiscal Quarter 2018 Financial Results and Corporate Update
GlobeNewswire 06/08/2018 Oxford BioMedica, UK Cystic Fibrosis Gene Therapy Consortium, Boehringer Ingelheim and Imperial Inno...
GlobeNewswire 14/06/2018 Global Viral Vectors and Plasmid DNA Manufacturing Market Report, 2018-2030 with Presentation of Ove...
GlobeNewswire 08/06/2018 T-Cell Immunotherapy Market, 2030 - Competitive Landscape Features a Mix of Established Players and ...